Literature DB >> 21970951

Early steps of follicular lymphoma pathogenesis.

Sandrine Roulland1, Mustapha Faroudi, Emilie Mamessier, Stéphanie Sungalee, Gilles Salles, Bertrand Nadel.   

Abstract

Follicular lymphoma (FL) pathogenesis is a complex and fascinating multi-hit process, escalating along successive derailments of the distinctive molecular and cellular mechanisms paving B-cell differentiation and activation. This progressive subversion of B-cell receptor diversification mechanisms and B-cell homeostasis likely occurs during a protracted preclinical phase of asymptomatic growth, in which premalignant clones already disseminate and establish "niches" in secondary lymphoid organs. Following FL diagnosis, a parallel indolent behavior is observed in most patients, slowly progressing over a period of many years, to eventually generate a highly refractory (and in some case transform into an aggressive subtype of) lymphoma. Novel insights in human germinal center B-cell biology recently allowed a more comprehensive understanding of the various illegitimate events sequentially involved in the premalignant progression phases. In this review, we will discuss how these new data have modified our perception of early FL pathogenesis, the new questions and challenges it opened up, and how this knowledge could impact on innovative programs of early detection, follow-up, and patient management.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21970951     DOI: 10.1016/B978-0-12-385991-4.00001-5

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  40 in total

1.  Follicular lymphomas: a tapestry of common and contrasting threads.

Authors:  Elaine S Jaffe
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

2.  Origin and migration of follicular lymphoma cells.

Authors:  Philip M Kluin
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

Review 3.  The biology of aging and lymphoma: a complex interplay.

Authors:  Clémentine Sarkozy; Gilles Salles; Claire Falandry
Journal:  Curr Oncol Rep       Date:  2015-07       Impact factor: 5.075

4.  CREBBP gene mutations are frequently detected in in situ follicular neoplasia.

Authors:  Janine Schmidt; Joan Enric Ramis-Zaldivar; Irina Bonzheim; Julia Steinhilber; Inga Müller; Andrea Haake; Shan Chi Yu; Mark Raffeld; Falko Fend; Itziar Salaverria; Reiner Siebert; Elaine S Jaffe; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

Review 5.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

6.  Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.

Authors:  Falko Fend; Leticia Quintanilla-Martínez
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

7.  Haematological cancer: the translocation behind follicular lymphoma development.

Authors:  Clémentine Sarkozy; Bertrand Coiffier
Journal:  Nat Rev Clin Oncol       Date:  2014-06-17       Impact factor: 66.675

8.  Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.

Authors:  Janice M Spence; Andrew Abumoussa; John P Spence; W Richard Burack
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

Review 9.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

10.  Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts.

Authors:  Clémentine Sarkozy; Matthew J Maurer; Brian K Link; Hervé Ghesquieres; Emmanuelle Nicolas; Carrie A Thompson; Alexandra Traverse-Glehen; Andrew L Feldman; Cristine Allmer; Susan L Slager; Stephen M Ansell; Thomas M Habermann; Emmanuel Bachy; James R Cerhan; Gilles Salles
Journal:  J Clin Oncol       Date:  2018-11-27       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.